Journal for ImmunoTherapy of Cancer (Nov 2023)
323 Preclinical development of AB-1015, an integrated circuit T cell therapy containing an ALPG/MSLN logic gate and FAS/PTPN2 shRNA-miR, for the treatment of ovarian cancer
Abstract
No abstracts available.